Cargando…

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma

BACKGROUND: Patients with multiple myeloma (MM) were excluded from the original SARS-CoV-2 mRNA vaccine trials, which may influence vaccine hesitancy in this population. We prospectively characterized the safety and immunogenicity of two-dose SARS-CoV-2 mRNA vaccination in 44 patients with MM, who u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greenberg, Ross S., Ruddy, Jake A., Boyarsky, Brian J., Werbel, William A., Garonzik-Wang, Jacqueline M., Segev, Dorry L., Imus, Philip H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711688/ https://www.ncbi.nlm.nih.gov/pubmed/34961488 http://dx.doi.org/10.1186/s12885-021-09097-5

Ejemplares similares

SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
por: Hallett, Andrew M., et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients
por: Strauss, Alexandra T., et al.
Publicado: (2022)

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021)

Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States
por: Bisen, Shivani S., et al.
Publicado: (2022)

SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19
por: Werbel, William A., et al.
Publicado: (2022)

Letter to the editor: Six‐month antibody kinetics and durability in liver transplant recipients after two doses of SARS‐CoV‐2 mRNA vaccination
por: Chang, Amy, et al.
Publicado: (2022)

Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients
por: Alejo, Jennifer L., et al.
Publicado: (2022)

Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine
por: Ou, Michael T., et al.
Publicado: (2021)

Effects of COVID19 Pandemic on Pediatric Kidney Transplant in the United States
por: Charnaya, Olga, et al.
Publicado: (2020)

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
por: Frey, Sarah, et al.
Publicado: (2022)

Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination
por: Frey, Sarah, et al.
Publicado: (2021)

Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses
por: Strauss, Alexandra T., et al.
Publicado: (2021)

A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
por: Karaba, Andrew H., et al.
Publicado: (2021)

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
por: Karaba, Andrew H., et al.
Publicado: (2022)

Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
por: Hughes, Robert M., et al.
Publicado: (2023)

Effects of COVID-19 pandemic on pediatric kidney transplant in the United States
por: Charnaya, Olga, et al.
Publicado: (2020)

Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Frey, Sarah, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients
por: Mitchell, Jonathan, et al.
Publicado: (2022)

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
por: Chiang, Teresa PY, et al.
Publicado: (2022)

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

48390 Racial and Ethnic Disparities in Pediatric Kidney Transplantation - Has KAS made a difference?
por: Charnaya, Olga, et al.
Publicado: (2021)

Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
por: Teles, Mayan S, et al.
Publicado: (2022)

Early Experiences With COVID-19 Testing in Transplantation
por: Boyarsky, Brian J., et al.
Publicado: (2020)

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Tsipotis, Evangelos, et al.
Publicado: (2023)

Messenger of safety.
por: Clay, R
Publicado: (1998)

Addressing Racial Disparities in Live Donor Kidney Transplantation Through Education and Advocacy Training
por: King, Elizabeth A., et al.
Publicado: (2020)

175 The Unfinished Journey towards Transplant Equity: an analysis of racial/ethnic disparities for children in the post-KAS era
por: Charnaya, Olga, et al.
Publicado: (2022)

Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
por: Motter, Jennifer D., et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on transplantation by income level and cumulative COVID-19 incidence: a multinational survey study
por: Sandal, Shaifali, et al.
Publicado: (2022)

FUNCTIONAL INDEPENDENCE, ACCESS TO KIDNEY TRANSPLANTATION, AND WAITLIST MORTALITY
por: Chu, Nadia M, et al.
Publicado: (2019)

Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients
por: Chiang, Teresa Po-Yu, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community
por: Strauss, Alexandra T., et al.
Publicado: (2020)

Quantifying excess deaths among solid organ transplant recipients in the COVID‐19 era
por: Massie, Allan B., et al.
Publicado: (2022)

Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
por: Hallett, Andrew, et al.
Publicado: (2021)

Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction
por: Eastman, Jacqueline, et al.
Publicado: (2022)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

Pretransplant Hepatitis C Virus Treatment Decreases Access to High-quality Livers
por: Strauss, Alexandra T., et al.
Publicado: (2021)

COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge
por: Cochran, Willa, et al.
Publicado: (2022)

Racial differences in inflammation and outcomes of aging among kidney transplant candidates
por: Shrestha, Prakriti, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v54tm8g9laqhcg270sg45i4440